One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Flashback Foreword: Kinase Mutations and Imatinib Response in Patients With Metastatic GI Stromal Tumor.
Maki, Robert G. MD, PhD, FACP, FASCO 1,2,3,
doi : 10.1200/JCO.23.00213
Volume 41(31) pgs. 4827-4941 November 1, 2023
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor.
Heinrich, Michael C.; Corless, Christopher L.; Demetri, George D.; Blanke, Charles D.; von Mehren, Margaret; Joensuu, Heikki; McGreevey, Laura S.; Chen, Chang-Jie; Van den Abbeele, Annick D.; Druker, Brian J.; Kiese, Beate; Eisenberg, Burton; Roberts, Peter J.; Singer, Samuel; Fletcher, Christopher D.M.; Silberman, Sandra; Dimitrijevic, Sasa; Fletcher, Jonathan A.
doi : 10.1200/JCO.22.02771
A Positive Distress Screen[horizontal ellipsis]Now What? An Updated Call for Integrated Psychosocial Care.
Tsao, Phoebe A. MD, MSc 1,2,,; Fann, Jesse R. MD, MPH 3,4; Nevedal, Andrea L. PhD 2; Bloor, Lindsey E. PhD 5,6; Krein, Sarah L. PhD 2,7; Caram, Megan E.V. MD, MSc 1,2
doi : 10.1200/JCO.22.02719
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG Oncology.
Weiss, Aaron R. DO 1,,; Chen, Yen-Lin MD 2; Scharschmidt, Thomas J. MD 3,; Xue, Wei PhD 4; Gao, Zhengya MS 4; Black, Jennifer O. MD 5; Choy, Edwin MD, PhD 2,; Davis, Jessica L. MD 6,; Fanburg-Smith, Julie C. MD 7; Kao, Simon C. MD 8; Kayton, Mark L. MD 9,; Kessel, Sandy BA 10; Lim, Ruth MD 2,; Million, Lynn MD 11; Okuno, Scott H. MD 12,; Ostrenga, Andrew PharmD 13,; Parisi, Marguerite T. MD 14; Pryma, Daniel A. MD 15,; Randall, R. Lor MD 16,; Rosen, Mark A. MD 15; Shulkin, Barry L. MD 17,; Terezakis, Stephanie MD 18; Venkatramani, Rajkumar MD 19; Zambrano, Eduardo MD 20; Wang, Dian MD 21; Hawkins, Douglas S. MD 14,; Spunt, Sheri L. MD, MBA 11,
doi : 10.1200/JCO.23.00045
Optimizing Dosing of Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer: A Reminder That More Is Not Always Better.
Hoe, Hui Jing MBBS 1; Solomon, Benjamin J. PhD, MBBS 1,2,,
doi : 10.1200/JCO.23.01768
Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial.
Goto, Koichi MD, PhD 1,,; Goto, Yasushi MD, PhD 2,; Kubo, Toshio MD, PhD 3,; Ninomiya, Kiichiro MD, PhD 4,; Kim, Sang-We MD, PhD 5; Planchard, David MD, PhD 6,; Ahn, Myung-Ju MD, PhD 7,; Smit, Egbert F. MD, PhD 8,; de Langen, Adrianus Johannes MD, PhD 9,; Perol, Maurice MD 10,; Pons-Tostivint, Elvire MD, PhD 11,; Novello, Silvia MD, PhD 12,; Hayashi, Hidetoshi MD, PhD 13,; Shimizu, Junichi MD, PhD 14,; Kim, Dong-Wan MD, PhD 15,; Kuo, Chih-Hsi MD, PhD 16,; Yang, James Chih-Hsin MD, PhD 17,; Pereira, Kaline MD, PhD 18,; Cheng, Fu-Chih PhD 18,; Taguchi, Ayumi PharmD 19,; Cheng, Yingkai MD, PhD 18,; Feng, Wenqin PhD 18,; Tsuchihashi, Zenta PhD 18,; Janne, Pasi A. MD, PhD 20,
doi : 10.1200/JCO.23.01361
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial.
Baek, Soo Yeon MD, MSc 1,2,; Noh, Woo Chul MD, PhD 3; Ahn, Sei-Hyun MD, PhD 4; Kim, Hyun-Ah MD, PhD 5,; Ryu, Jai Min MD, PhD 6,; Kim, Seung Il MD, PhD 7,; Lee, Eun-Gyeong MD, MSc 8; Im, Seock-Ah MD, PhD 9,; Jung, Yongsik MD, MSc 2; Park, Min Ho MD, PhD 10; Park, Kyong Hwa MD, PhD 11,; Kang, Su Hwan MD, PhD 12; Jeong, Joon MD, PhD 13,; Park, Eunhwa MD, PhD 14; Kim, Sung Yong MD, PhD 15; Lee, Min Hyuk MD, PhD 16; Kim, Lee Su MD, PhD 17; Lim, Woosung MD, PhD 4; Kim, Seonok MSc 18; Kim, Hee Jeong MD, PhD 1,
doi : 10.1200/JCO.23.00557
Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.
de Vries, Hielke M. MSc 1,2; Rafael, Tynisha S. MSc 2; Gil-Jimenez, Alberto MSc 1,3; de Feijter, Jeantine M. PhD 1; Bekers, Elise MSc 4; van der Laan, Elsbeth MSc 1; Lopez-Yurda, Marta PhD 5; Hooijberg, Erik PhD 4; Broeks, Annegien PhD 6; Peters, Dennis BSc 6; Seignette, Iris M. BSc 4; Pos, Floris J. PhD 7,; Horenblas, Simon MD, PhD 2; van Rhijn, Bas W.G. PhD 2,; Jordanova, Ekaterina S. PhD 2; Brouwer, Oscar R. PhD 2; Schaake, Eva PhD 7,; van der Heijden, Michiel S. PhD 1,3,,
doi : 10.1200/JCO.22.02894
Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study.
Li, Jing PhD 1,2,3,4; Gao, Ju MD 5,6; Liu, Ansheng MS 7; Liu, Wei MS 8; Xiong, Hao MD 9; Liang, Changda MD 10; Fang, Yongjun MD 11; Dai, Yunpeng PhD 12; Shao, Jingbo PhD 13; Yu, Hui MD 14; Wang, Lingzhen MD, PhD 15; Wang, Li MS 16; Yang, Liangchun MD 17; Yan, Mei PhD 18; Zhai, Xiaowen MD 19; Shi, Xiaodong MD, PhD 20; Tian, Xin MD 21; Ju, Xiuli MD, PhD 22; Chen, Yan MD, PhD 23; Wang, Jing MS 24; Zhang, Leping MD, PhD 25; Liang, Hui MD 26; Chen, Sen MD 27; Zhang, Jingrong MS 28; Cao, Haixia MS 29; Jin, Jiao MD 30; Hu, Qun MD 31; Wang, Junlan MS 32; Wang, Yilin MD 33; Zhou, Min MD 34; Han, Yueqin MS 35; Zhang, Rong MS 36; Zhao, Weihong MD, PhD 37; Wang, Xiaoli MS 38; Lin, Limin MS 39; Zhang, Ruidong MD 1,2,3,4; Gao, Chao PhD 2,3,4,40,41; Xu, Liting PhD 42; Zhang, Yuanyuan MS 1,2,3,4; Fan, Jia MS 1,2,3,4; Wu, Ying MS 1,2,3,4; Lin, Wei MD 1,2,3,4; Yu, Jiaole PhD 1,2,3,4; Qi, Peijing PhD 1,2,3,4; Huang, Pengli MS 1,2,3,4; Peng, Xiaoxia PhD 43; Peng, Yaguang PhD 43; Wang, Tianyou MD 1,2,3,4; Zheng, Huyong MD, PhD 1,2,3,4,; for the Chinese Children's Leukemia Group
doi : 10.1200/JCO.22.02836
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.
Daver, Naval G. MD 1,,; Vyas, Paresh FRCP 2,; Kambhampati, Suman MD 3; Al Malki, Monzr M. MD 4,; Larson, Richard A. MD 5,; Asch, Adam S. MD 6,; Mannis, Gabriel MD 7,; Chai-Ho, Wanxing MD 8,; Tanaka, Tiffany N. MD 9,; Bradley, Terrence J. MD 10,; Jeyakumar, Deepa MD 11,; Wang, Eunice S. MD 12,; Sweet, Kendra MD 13,; Kantarjian, Hagop M. MD 1,; Garcia-Manero, Guillermo MD 1,; Komrokji, Rami MD 13,; Xing, Guan PhD 14,; Ramsingh, Giridharan MD 14,; Renard, Camille MSc 14,; Zeidner, Joshua F. MD 15,; Sallman, David A. MD 13,
doi : 10.1200/JCO.22.02604
Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education.
Kilbride, Madison PhD 1; Egleston, Brian L. PhD 2,; Chung, Wendy K. MD, PhD 3; Olopade, Olufunmilayo MD 4,; Maxwell, Kara N. MD, PhD 5; Shah, Payal MD 5,; Churpek, Jane E. MD 4,; Fleisher, Linda PhD 2,; Terry, Mary Beth PhD 6; Fetzer, Dominique BA 5; Gaieski, Jill Bennett PhD, JD 5; Bulafka, Jessica BS 6; Espinal, Aileen BS 6; Karpink, Kelsey BA 5; Walser, Sarah MD 5; Singleton, Davone BA 5; Palese, Monica BS 4; Siljander, Ilona BS 4; Brandt, Amanda MS, CGC 5; Clark, Dana MS, CGC 5,; Koval, Carrie MS, CGC 7; Wynn, Julia MS, CGC 8,; Long, Jessica M. MS, CGC 5,; McKenna, Danielle MS, CGC 5; Powers, Jacquelyn MS, CGC 5,; Nielsen, Sarah MS, CGC 4,; Domchek, Susan M. MD 5,; Nathanson, Katherine L. MD 9,; Bradbury, Angela R. MD 5,10,,
doi : 10.1200/JCO.22.00516
Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry.
Koscielniak, Ewa MD 1,2,; Timmermann, Beate MD 3; Munter, Marc MD 4; Weclawek-Tompol, Jadwiga MD 5; Ladenstein, Ruth MD 6,; Niggli, Felix MD 7; Ljungman, Gustaf MD 8; Brecht, Ines B. MD 9,; Blank, Bernd MD 1; Hallmen, Erika BSc 1; Scheer, Monika MD 10; Fuchs, Joerg MD 11; Seitz, Guido MD 12; Blattmann, Claudia MD 1,2; Sparber-Sauer, Monika MD 1,2; Klingebiel, Thomas MD 13,
doi : 10.1200/JCO.22.02673
Clinical Practice Strategies to Address Sexual Health in Female Cancer Survivors.
Arring, Noel PhD, DNP, RN 1,; Barton, Debra L. PhD, RN, FAAN, FASCO 1,,; Reese, Jennifer B. PhD, FSBM 2
doi : 10.1200/JCO.23.00523
WHO or International Consensus Classification: Is the Difference Worth It?.
Cree, Ian A. MBChB, PhD; Khoury, Joseph D. MD
doi : 10.1200/JCO.23.01172
Identification of Cardiovascular Disease Risk Factors in Testicular Cancer Survivors and the Impact on Quality of Life.
Wang, Gang MD; Zhuo, Ning MD; Liu, Zhichun MD
doi : 10.1200/JCO.23.01122
Reply to G. Wang et al.
Lubberts, Sjoukje MD; van Leeuwen, Flora E. PhD; Schaapveld, Michael PhD; Gietema, Jourik A. MD, PhD
doi : 10.1200/JCO.23.01336
Erratum: Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial.
doi : 10.1200/JCO.23.01849
